Endymed Balance Sheet Health

Financial Health criteria checks 4/6

Endymed has a total shareholder equity of $13.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.2M and $5.0M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$6.97m
EquityUS$13.25m
Total liabilitiesUS$4.96m
Total assetsUS$18.21m

Recent financial health updates

No updates

Recent updates

Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Nov 07
Endymed Ltd's (TLV:ENDY) Share Price Boosted 43% But Its Business Prospects Need A Lift Too

Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Sep 23
Endymed Ltd's (TLV:ENDY) 25% Dip In Price Shows Sentiment Is Matching Revenues

Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Aug 06
Endymed Ltd (TLV:ENDY) Investors Are Less Pessimistic Than Expected

Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

May 24
Here's What's Concerning About Endymed's (TLV:ENDY) Returns On Capital

Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Mar 11
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up

Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

Oct 23
Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jul 17
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Apr 03
Returns Are Gaining Momentum At Endymed (TLV:ENDY)

Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

Nov 18
Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Jun 03
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Feb 13
Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price

Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Nov 28
Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching

Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Oct 31
Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital

Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Aug 29
Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?

Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

Aug 01
Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist

We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Apr 11
We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)

Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 15
Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Jan 10
Returns On Capital - An Important Metric For Endymed (TLV:ENDY)

Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Dec 14
Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?

Financial Position Analysis

Short Term Liabilities: ENDY's short term assets ($15.1M) exceed its short term liabilities ($3.7M).

Long Term Liabilities: ENDY's short term assets ($15.1M) exceed its long term liabilities ($1.2M).


Debt to Equity History and Analysis

Debt Level: ENDY is debt free.

Reducing Debt: ENDY had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if ENDY has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if ENDY has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 13:55
End of Day Share Price 2024/12/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Endymed Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution